Stay updated on Venetoclax Regimen to Prevent AML Relapse Clinical Trial
Sign up to get notified when there's something new on the Venetoclax Regimen to Prevent AML Relapse Clinical Trial page.

Latest updates to the Venetoclax Regimen to Prevent AML Relapse Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedNew revision entry v3.4.2 added and revision v3.4.1 removed in the Study Record Versions. These are administrative history updates and do not affect study details; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedRevision history now shows the addition of v3.4.1 and the removal of v3.4.0, indicating a minor administrative update to the record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedUI enhancements include showing the glossary by default, color-coded highlights for additions and deletions, and updated revision/version information in the history.SummaryDifference1%

- Check42 days agoChange DetectedRecord history updated to revision v3.3.4 and the removal of v3.3.3, a minor metadata update visible in the history table. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedNew revision entry v3.3.3 was added to the history; the HHS Vulnerability Disclosure link and prior revision v3.3.2 entry were removed. These changes do not affect the study details or records. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check77 days agoChange DetectedLatest version shows the study status updated to Terminated and notes that the research center conducted a more comprehensive study. It also adds new sections (Contacts/Locations, Study Design, Study Status, Study Identification, Recruitment Status) and removes the previous 'Recruiting' status along with the location 'Institute of Hematology & Blood Diseases Hospital, China'.SummaryDifference2%

Stay in the know with updates to Venetoclax Regimen to Prevent AML Relapse Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax Regimen to Prevent AML Relapse Clinical Trial page.